Skip to content

Clinical trials

Completed Musculoskeletal Diseases trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Musculoskeletal Diseases Status: Completed Country / region: Australia Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20091
20122
20131
20152
20164
20174
20182
20191
20201
20211
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie7
QED Therapeutics, a BridgeBio company3
Amgen2
BioMarin Pharmaceutical2
PTC Therapeutics2
University of Melbourne2
Catabasis Pharmaceuticals1
Endo USA Inc., a Keenova Therapeutics Company1
Mesoblast, Ltd.1
The University of Queensland1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Musculoskeletal Diseases22
Joint Diseases9
Arthritis8
Bone Diseases8
Genetic Diseases, Inborn7
Achondroplasia5
Arthritis, Rheumatoid5
Dwarfism5
Osteochondrodysplasias5
Bone Diseases, Developmental3

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.